Search results for "Authentic C_IBP_2208 Exam Questions, SAP Related C_IBP_2208 Certifications: Certified Application Associate - SAP IBP for Supply Chain Pass Certainly đź Download â© C_IBP_2208 âȘ for free by simply searching on †www.pdfvce.com âź âValid C_IBP_2208 Exam Answers"
| Results 1 - 65 of 65
|
Page 1 of 1
|
|
Sorted by: Relevance | Sort by: Date
|
Results per-page: 10 | 20 | 50 | All
|
[…]has prioritized smoking cessation among people who use substances through the Tobacco-Free for Recovery Initiative, which includes an intervention aimed at supporting substance use disorder treatment programs in implementing tobacco-free grounds. Dr. McCuistian led an examination of changes in client smoking prevalence, tobacco use behaviors, and receipt of cessation services among the first seven programs participating in the initiative. Program clients completed cross-sectional surveys at the start of the intervention (baseline: n = 249), at an interim timepoint post-baseline (interim: n = 275), and at the end of the intervention 15 months later (post-intervention: n = 219). Over the course […]
[…]R. I., D. S. O’Leary, et al. (2002). “Effects of frequent marijuana use on memory-related regional cerebral blood flow.” Pharmacol Biochem Behav 72(1-2): 237-50. It is uncertain whether frequent marijuana use adversely affects human brain function. Using positron emission tomography (PET), memory-related regional cerebral blood flow was compared in frequent marijuana users and nonusing control subjects after 26+ h of monitored abstention. Memory-related blood flow in marijuana users, relative to control subjects, showed decreases in prefrontal cortex, increases in memory-relevant regions of cerebellum, and altered lateralization in hippocampus. Marijuana users differed most in brain activity related to episodic memory encoding. […]
[…]Guidelines by Chapter: CHAPTER 1 PATIENT ASSESSMENT AND DIAGNOSIS FLIPBOOK PDF CHAPTER 2 MEDICATION-ASSISTED TREATMENT FLIPBOOK PDF CHAPTER 3 MANAGING PAIN IN PATIENTS WITH OPIOID USE DISORDER FLIPBOOK PDF CHAPTER 4 PREGNANCY AND NEONATAL WITHDRAWAL FLIPBOOK PDF CHAPTER 5 COMORBID POLYSUBSTANCE USE FLIPBOOK PDF CHAPTER 6 CONCURRENT MEDICAL CONDITIONS FLIPBOOK PDF CHAPTER 7 COMORBID PSYCHIATRIC ILLNESS FLIPBOOK PDF CHAPTER 8 LABORATORY DATA FLIPBOOK PDF This publication made possible through a SAMHSA Opioid State Targeted Response […]
[…]Adolescent Substance Use Standards For Access To Addiction Medicine Services Use of Buprenorphine-Naloxone in the Emergency Department Insurance Barriers to Accessing Treatment of Opioid Use Disorders Identified by California Physicians Minimum Insurance Benefits for Patients with Opioid Use Disorder Minimum Insurance Benefits for Patients with Alcohol Use Disorder Minimum Insurance Benefits for Patients with Nicotine and Tobacco Use Disorder Guidelines Item Name Posted By Date Posted CSAM Guidelines Chapter 1 PDF (147.27 KB) Administration 7/2/2019 CSAM Guidelines Chapter 2 PDF (230.02 KB) Administration 7/2/2019 CSAM Guidelines Chapter 3 PDF (102.33 KB) Administration 7/2/2019 CSAM Guidelines Chapter 4 PDF (171.99 KB) Administration 7/2/2019 CSAM […]
[…]Medicine. Additional requirements include either minimum time in practice or completion of non-ACGME-accredited fellowship training in Addiction Medicine. Two options are available in the Practice Pathway: Documents and Verifications *The Addiction Medicine Practice Pathway will expire in 2025. Beginning in 2026, all applicants for certification in Addiction Medicine must successfully complete an ACGME-accredited Addiction Medicine fellowship program. This subspecialty certifying exam will be given annually throughout this period.â See you this Summer, August 30 – September […]
[…]osteopathic medicine. Associate Member: ASAM: $285 | CSAM: $110 ($395 Total)Open to individuals non-physicians who teach, conduct research or provide clinical care for individuals who are at risk for, or have a substance use disorder. Early Career Physicians: ASAM: $275 | CSAM: $113 ($388 Total)Physicians members in their first two years after completing an accredited residency or fellowship program or in their first two years of practicing Addiction Medicine as a significant portion of their practice. Residents: ASAM: $45 | CSAM: $30 ($75 Total)Interns or residents, with a valid medical license or an equivalent certifying document. Resident membership is limited […]
[…]Assistance Programs, juvenile justice interventions, emergency room presentations of cannabis-related urgencies/emergencies, rates of use, and the publicâs perception of risk associated with cannabis use. B. Professional Research: What constitutes treatment and who gets it; complete separation of medical and recreational cannabis. C. Technical Research: Assessment of cannabis intoxication and driving risks, clinical effects of high-potency extracts and edible products Above Statement Issued October 12, 2015 CSAM Task Force on Cannabis: Itai Danovitch, MD, MBA (co-chair)Monika Koch, MD (co-chair)Seth Ammerman, MDPeter Banys, MD, MScAngella Barr, MDTimmen Cermak, MDIhor Galarnyk, MDRandolph Holmes, MDBrian Hurley, MD, MBACathy McDonald, MDMario San BartolomĂ©, Jr., MD, […]
[…]educators will cover 16 key topic areas, with sample exam questions and rationale provided for answers. Test-taking and study tips will be covered. Attendees will have access to review these recorded sessions through November. Access to the High Yield Question Bank is included. Addiction Medicine Review Course: The 2021 all-virtual CSAM conference continues the biannual tradition of reviewing the essentials of addiction treatment while incorporating current evidence-based practices in this everchanging field. The planning committee has selected engaging, dynamic speakers. Read […]
[…]state drug laws. âWe got about 20 people together and drove back and forth to Sacramento to lobby for change. Senator George Moscone became an ally and the CMA was on our side. We took the issue to one of the early Haight-Ashbury Free Medical Clinic Conferences and got grass roots support. We got the law changed at last,â Bromley recalled. CSAMâs efforts to move the treatment of addiction into mainstream medicine involved both getting recognition within the CMA and also getting support for the new organization within academic medicine. The connection with CMA was strengthened by Gail Jara who had joined the CMA […]
[…]we serve. This is an incredible opportunity to support the change management process for a once-in-a-generation moment of behavioral health reform in California. Full-time telework permitted. Board certifications in psychiatry and addiction medicine or addiction psychiatry preferred. For more information, please visit the Cal Careers website. Please share with your networks. Thank you! ï»żFor any questions, please contact the DHCS Hiring Manager for this position, Jamie Shigetoshi, at Jamie.Shigetoshi@dhcs.ca.gov. Please feel free to cc Ivan Bhardwaj […]
[…]
[…]submitted by mail, which will delay the processing of the license application. The DOCS registration form is available on the Boardâs website. DOCS registration forms and questions about registering may be emailed to […]
[…]Treatment Work Group meeting. We look forward to your feedback. Please be in touch with questions. Thank you. Article provided by […]
[…]IMMEDIATE RELEASE: February 27, 2023Statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids WASHINGTON, D.C. â The U.S. Supreme Court announced today that it will not hear R.J. Reynoldsâ appeal of a lower court ruling upholding Los Angeles Countyâs law prohibiting the sale of flavored tobacco products. This decision is a tremendous victory for kids and public health. It allows Los Angeles Countyâs law to remain in effect, while also preserving the authority of states and localities across the country to enact similar lifesaving measures. R.J. Reynolds and other tobacco companies have desperately fought these laws so they can continue to […]
[…]year. In honor of this momentous occasion, this yearâs conference will feature a new approach by combining the traditional review course with panels highlighting cutting edge practices in addiction medicine. We will offer plenary sessions on all major substance use disorders focusing on epidemiology, diagnosis, and treatment, geared towards ABPM Board exam preparation. Furthermore, we will feature multidisciplinary panels for the first time at a CSAM conference, addressing topics as diverse as: treatment of ADHD in substance use disorders, adolescent addiction medicine, frontiers in harm reduction, ketamine and other novel treatments, and alcohol withdrawal management other than benzodiazepines (See schedule […]
[…]reported a 48 percent reduction in primary drug use, a 53 percent reduction in alcohol and drug-related medical visits, and an 80 percent reduction in criminal activity. (ONDCP, 2002; CSAT, 2000) Evidence-based treatment modalities exist and should guide treatment programs. 7. Youth Treatment must be Comprehensive. Substance dependence is a chronic medical condition requiring ongoing support and monitoring, especially with youth and young adults. As with other chronic conditions, treatment works, but does not cure. A statewide network of residential treatment centers should be established for those who are unable to be treated effectively in intensive outpatient programs. Treatment programs […]
[…]use disorders, is pleased that the California Senate has passed SB 57. Our organization is a co-sponsor of SB 57, and we believe this bill will save lives here in California,â said Randolph Holmes, MD, FAAFP, DFASAM, Chair of Public Policy for CSAM. âWe urge Governor Newsom to sign this bill into law as quickly as possible so we can move forward with these necessary services for our community.â Overdose prevention programs (OPPs) â also known as supervised consumption services (SCS) â such as those that could be established under this bill, provide a sanctioned, safe space for people to […]
[…]overall costs of substance abuse in the United States, including productivity and health- and crime-related costs, exceed $600 billion annually. This includes approximately $181 billion for illicit drugs, $193 billion for tobacco, and $235 billion for alcohol. As staggering as these numbers are, they do not fully describe the breadth of destructive public health and safety implications of drug abuse and addiction, such as family disintegration, loss of employment, failure in school, domestic violence, and child abuse. How to tell if you drink too much? Frequently Asked Questions Adverse Effects of Marijuana Marijuana’s Addictive Potential Background Information Addiction is a […]
[…]conducted health policy research as a Fulbright Scholar in Central America. Dr. Herring is board-certified in Emergency Medicine, Addiction Medicine, and Pain Medicine, and is Associate Clinical Professor of Emergency Medicine, at […]
[…]addiction, alcoholism, and psychoactive dependence, represents our countryâs number-one public health problem. Complementing this is the rise in prescription opioid abuse, particularly in adolescents, where prescription drug overdose deaths in 2008 exceeded all the overdose deaths for heroin, methamphetamine, and cocaine combined. Substance abuse is now the leading cause of death in young people, exceeding even traffic fatalities (Knudsen 2009). Alcoholism as a disease was clearly described as long ago as the late 1700s by Dr. Benjamin Rush, a physician and signer of the Declaration of Independence (Katcher 1993). However, it wasnât until the formation of Alcoholics Anonymous (AA) in […]
[…]on upcoming Tobacco Industry Sparked referendum Prepare to inform others about the need for ACTION on SB796 (Hill), the menthol and flavored tobacco ban which CSAM supported and Governor Newsom signed. Because the ban on flavored products is being held up by a tobacco industry sponsored referendum, it will be important to inform patients, colleagues, friends and others that THEY MUST VOTE YES on the referendum in order to enact the ban that has been delayed, resulting in the loss of thousands of lives and recruitment of thousands of teens to smoking and vaping. This referendum will likely appear on […]
[…]H. Reuter. The RAND Corporation is a nonprofit institution that helps improve policy and decision-making through research and analysis. All RAND occasional papers undergo rigorous peer review to ensure that they meet high standards for research quality and objectivity. This summary was prepared by Timmen Cermak, MD, President of the Californian Society of Addiction Medicine, and Itai Danovitch, MD. Portions are direct quotes, although quotation marks have been left out to make the text more readable. The current price for sinsemilla-grade marijuana in California is approximately $300-$450 per […]
[…]fathers, are four to nine times more likely to have problems with alcohol than children of non-alcoholic parents. Q: How big a problem is teen alcohol and drug use? A: Alcohol is the drug of choice for teens, but illegal drug use is a serious problem, too. About a third of all teens try illegal drugs, including marijuana, while more than half have used alcohol. By the time they reach their senior year in high school, more than 45 percent have tried illegal drugs while nearly three-quarters have used alcohol. More than half of high school seniors have been drunk. […]
[…]MD, DFASAMPrivate Practice, Chief Medical Officer, Bright Heart Health Chair, Committee on Education Mason Turner, MD, FASAMSenior Medical Director for Behavioral Health; Intermountain Healthcare Chair, Committee on Opioids Matthew A. Torrington, MD, ABAM, ABPM, AAFP, DFASAMPrivate Practice, Clinical Research, ACP UCLA School of Nursing Co-Chair, Committee on Membership & Communications Jean Marsters, MDLifelong Medical Care, Asian Health Services CSAM Presidents 1983-present 2023 Sharone Abramowitz, MD 2021 Karen Miotto, MD 2019 Anthony Albanese, MD 2017 David Kan, MD 2015 Monika Koch, MD 2013 Itai Danovitch, MD 2011 Jeffery Wilkins, MD 2009 Timmen Cermak, MD 2007 Judith Martin, MD 2005 David Pating, MD […]
For more information, contact csam@csam-asam.org. The following public policy platform represents the focus and direction CSAM will take in evaluating and responding to legislative and regulatory measures and serve as a guide for prioritizing initiatives and activities in […]
[…]working in the OTP is often the first medical provider with whom these patients establish a long-term therapeutic relationship so the OTP physician can be an important, even lifesaving, resource for patients enrolled in treatment, identifying the multiple medical problems that characterize chemical dependence and providing treatment or referrals to address these problems, said co-editor Deborah Stephenson, MD, MPH. When utilized by OTP physicians, the Guidelines serve to improve community safety and public health. A copy of the updated Guidelines can be downloaded for free at [PDF download]. Qualified OTP clinicians may request a free print copy of the Guidelines by […]
[…]heavy use increases the possibility that these “side effects” take a significant toll on one’s health. The following information briefly summarizes the health consequences of marijuana that have been documented by research studies. For further details and references, please refer to the section for “Healthcare Professionals.” The adverse effects on health caused by smoking marijuana can be divided into the following broad categories: Brain Function Short-Term Marijuana intoxication causes well defined impairments in the following brain functions: Memory, sense of time, sensory perception, attention span, problem solving, verbal fluency, reaction time, and psychomotor control. The short-term effects of marijuana last […]
[…]obtain the waiver to prescribe buprenorphine in office-based treatment of opioid use disorders. Non-member price for the online module is $199 for physicians. Residents are free and there are other discounts available. Register Here To achieve the remaining 4 hours required by the Medical Board of California Select from any of the following topics offered by CSAM, each offering 1.0 AMA PRA Category 1 Creditsâą. Buprenorphine Formulations and Clinical Challenges in Prescribing Buprenorphine â this online course is 1-hour. It is free for ASAM/CSAM members; $25 for non-members. Strategies to Increase Your Confidence with Buprenorphine Prescribing in Primary Care Real […]
BOARD EXAM PREPARATION TRACK and PRE-CONFERENCE WORKSHOPS INFORMATION:WEDNESDAY, AUGUST 21, 2024 Addiction Medicine Board Exam Preparation Track (7:30 a.m. â 4:30 p.m.)The Addiction Medicine Board Exam Preparation Workshop is designed for those preparing to take the American Board of Preventive Medicine (ABPM) Addiction Medicine Board Exam and is aligned with the Boardâs exam content Blueprint. The faculty of experienced educators will cover 16 key topic areas, with sample exam questions and rationale provided for answers. Test-taking and study tips will be covered. Registration for the all-day workshop includes access to the online High Yield Question Bank after the conclusion of […]
[…]Addiction Medicine American Board of Addiction Medicine Medical Education and Research Foundation for the Treatment of Alcoholism and Other Drug Dependencies (MERF) California Public Protection and Physician Health, Inc. (CPPPH) Related Resources – Visit sites below for more on addiction American Association for the Treatment of Opiate Dependence Addiction Technology Transfer Center Alcohol Addiction Center APA Division on Psychopharmacology Center for Education and Drug Abuse Center for Substance Abuse Treatments (CSAT) Drug Policy Alliance Ensuring Solutions to Alcohol Problems Ernest Gallo Clinic and Research Center Mental Health Resource Narcotics Anonymous National Alliance of Advocates for Buprenorphine Treatment The National Center on […]
[…]Requires a least one randomized controlled trial (RCT) as part of the evidence B. Requires well-controlled clinical studies, but no RCT C. Requires clinical experience of respected authorities Other frameworks make finer distinctions among different levels of evidence (e.g., Oxford Centre for EBM Levels of Evidence), but the thrust of each is the same. The âgold standardâ for credibility is met by randomized, double-blind, placebo-controlled trials, with multi-site studies being preferred to single-site studies. The unique advantage of randomization is that it enables researchers to evaluate whether the intervention (or product) itself, as opposed to other factors, causes any observed […]
[…]on addressing questions patients frequently ask their physicians about its use, and based on up-to-date science, suggest ways to improve physician-patient discussions about cannabis and apply them to a clinical setting. Presenter: Itai Danovitch, MD Dr. Danovitch is President of the California Society of Addiction Medicine, and Chair for the Department of Psychiatry and Director of Addiction Psychiatry at Cedars Sinai Medical Center. His research interests have focused on substance use disorders, particularly marijuana, as well as the integration of medical and mental health services. Educational Objectives Upon completion of this program, participants should be able to: Answer patientsâ questions […]
[…]diabetic. All too often CSAM physicians see their patients work towards a false goal of medication-free abstinence that is reinforced by societal prejudice and a system of reimbursement that pays for detoxification but not maintenance. When patients risk relapse back to illicit opiates, they jeopardize relationships with the ones they love. Patients who relapse back to opiate addiction endanger their jobs, threaten their quality of life, and most importantly, imperil their health. The risks of relapse are especially dangerous amidst the current HIV and hepatitis C epidemics Methadone maintenance is a treatment for opiate addiction that is safe, efficacious, and […]
[…]of Medical Specialties (ABMS). Additionally, the locator lists the specialty information for each member (as supplied by the member) and information about each member’s current positions. Only current CSAM members are listed in the locator. If you are a physician, addiction medicine professional, or a medical student and would like to be included in the physician locator, the first step is to join ASAM/CSAMÂ here. If you would like to be removed from the listing, please notify us here. Consumer […]
[…]all of which CSAM supports: AB 2651 (Bains) Support AB 2651 would create, upon appropriation by the Legislature, the Licensed Alcohol Drug Counselor Board within the Department of Consumer Affairs. The bill would require the board to establish regulations and standards for the licensure of alcohol drug counselors, as specified. The bill would authorize the board to collaborate with the Department of Health Care Access and Information regarding behavioral health professions, review sunrise review applications for emerging behavioral health license and certification programs and refer complaints regarding behavioral health workers to appropriate agencies, as specified. AB 2115 (Haney) Support Under current law, […]
[…]of Preventive Medicine, Addiction Medicine Subspecialty Board Exam in 2024. Our other Wednesday Pre-conference workshops will focus on psychedelics, the state of the art in opioid use disorder treatment, addressing our child and adolescent populations, while MERF (Medical Education Research Foundation) will offer its popular MI (Motivational Interviewing) workshop on Wednesday as well. And last but not the least, MERF scholars and conference attendees will have an opportunity to share their research and other projects through multiple Poster Sessions over the course of conference. In short, whether you are a late, mid or early career physician, a physician in training, […]
CSAM News Spring […]
[…]pleased to announce that we are hard at work developing our small group case discussions, a time-honored CSAM tradition. Our attendees consistently tell us that this is one of the many things that set CSAM conferences apart, as these discussions enhance both learning and community building. We have been asked over the years why the case discussions donât include outcomes and I had the opportunity to discuss this with Dr. Steve Eickelberg, who is one of our cherished long-term CSAM members and who has written so many of the cases that you have been challenged by over the years. Hereâs […]
[…]prevention, recognition and treatment approaches that acknowledge addiction as a youth-onset condition. We are committed to: The CSAM Youth and Prevention Committee is unwavering in its dedication to improving the prevention and recovery landscape, ensuring a brighter and more resilient future for our youth and society. Committee on Youth and Prevention Roster Committee on Membership & Communications The Committee on Membership & Communications is responsible for recruitment of new members into CSAM and promoting active participation among the membership. In addition, the Committee is responsible for all of CSAM’s regular publications such as the newsletter, email broadcasts, and the CSAM […]
[…]over the last 15 years-that this view of cannabinoid action on brain reward processes and reward-related behaviors is untenable. This paper reviews those data, and concludes that cannabinoids act on brain reward processes and reward-related behaviors in strikingly similar fashion to other addictive drugs. Pistis, M., Muntoni, A. L., Pillolla, G., Gessa, G. L. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological studyEur J Neurosci. 2002 Jun;15(11):1795-802. Abstract The nucleus accumbens (NAc) represents a critical site for the rewarding properties of diverse classes of drugs of abuse. Glutamatergic afferents to the […]
[…]in high amounts or with high frequency, is not equivalent to a substance use disorder b) The DSM-5-TR distinguishes between substance use and SUDs which should not necessarily be equated c) The frequency, duration, and amount of substance use alone have never been diagnostic criteria in the DSM, because those metrics do not correlate with a lack of control d) A positive drug test alone is not an indicator of a substance use disorder and e) substance use disorders are clinical conditions that should only be diagnosed by trained professionals and not the courts. This latter amicus was filed with […]
[…]either CSAM public policy or the policy of the American Society of Addiction Medicine. Presentation by Peter Banys, MD and Timmen Cermak, MD at the Addiction Medicine State of the Art 2011 Conference in Long Beach on October 14, 2011. This presentation is not CSAM public policy or the policy of the American Society of Addiction Medicine. Over 100 CSAM members registered their opinion in an online survey and many offered valuable comments about the Youth First Report submitted to the membership for a vote by CSAMâs Executive Council, which unanimously accepted the report at its meeting on October 14, […]
[…]the most effective known treatment for heroin dependence – yielding better results than drug-free outpatient treatment, therapeutic communities, and chemical dependency treatment. The benefits of methadone treatment are established by hundreds of scientific studies. Those studies make clear that methadone treatment is not only the gold standard intervention for heroin dependence, it is also effective at preventing HIV/AIDS, reducing criminal behavior, promoting health, and improving social productivity. What is more, there are almost no negative health consequences of long-term methadone treatment, even when it continues over an extended period of time. For these reasons, methadone treatment, including methadone maintenance, is […]
[…]shared members. Last Winter, MERF and the CSAM Membership Committee teamed up to submit a proof-of-concept paper to the California Health Care Foundation seeking funding to develop training for clinicians from race/ethnic groups underrepresented in medicine. Our request was not funded. Last Spring, MERF and the CSAM Membership Committee teamed up to submit an application for a MAT Access Points grant to the Sierra Foundation (CA DPH SOR-3 funds) designed to promote addiction prevention and treatment for opioids and stimulants to communities of color in California. We offered to develop an 11-month training spanning 2023-24 for 16 California clinicians who either a) identified as […]
[…]annual budget process. I encourage the author and stakeholders to engage with DHCS’s recently-formed Behavioral Health Stakeholder Advisory Committee to address concerns regarding youth substance use disorder treatment services. Sincerely, Gavin Newsomâ AB-920 (Petrie-Norris) was also vetoed: “To the Members of the California State Assembly: I am returning Assembly Bill 920 without my signature. This bill would eliminate an existing voluntary outpatient certification program. Beginning January 1, 2021, it would attempt to require an outpatient substance use disorder (SUD) recovery or treatment services facility which is not licensed under existing law, to obtain licensure from the Department of Health Care Services (DHCS) to provide […]
[…]visit the CSAM Education center to watch the new MAT webinars: Real Cases of Buprenorphine-Naloxone Treatment: What to do and how to do it? featuring CSAM members, Soraya Azari, MD, Kenneth Saffier, MD, FASAM and Scott Steiger, MD, FACP, FASAM. Transdermal Buprenorphine for Induction of Patients with Co-Morbid Pain featuring CSAM members, Soraya Azari, MD and Tauheed Zaman, MD. These webinars are FREE for CSAM members. These are two 2019 webinars on Medication Assisted Treatment (MAT) in primary care settings created by the California Society of Addiction Medicine (CSAM) with the support of a grant from the California Department of Healthcare Services (DHCS). We hope you enjoy the […]
[…]article about these bills that appeared on 9/18/2019 in the Orange County Register CSAMâs co-sponsored bill, AB-920 (Petrie-Norris), is on the Governorâs desk to sign. This bill would require outpatient centers, which are now unsupervised by the state, to be licensed, regulated, and to adopt treatment criteria set by ASAM as the minimum standard of care. Also on the Governorâs desk: AB-919 (Petrie-Norris) – would crack down on financial conflicts-of-interest among rehab operators SB-589 (Bates) – would prohibit rehabs and sober homes from making false or misleading advertising statements AB-290 (Wood) – would remove the financial incentive for treatment providers to lure people to California by promising […]
[…]and contractor to the American Society of Addiction Medicine (ASAM) to develop the ASAM certification exam. In 1987, she left CMA to devote her full time to CSAM. Retired since 2000, she has continued working with CSAM as a consultant on policy and projects related to physician health and well-being and on opioid addiction treatment. Garrett O’Connor, MD Receives Award Recognizing Lifetime Of Achievement Garrett OâConnor, MD, received an award on the opening evening of the California Society of Addiction Medicine’s (CSAM’s) State of the Art Conference at the Hyatt Regency in Long Beach, California, to honor the profound contributions […]
[…]plant, the class of chemicals similar in structure came to be known as cannabinoids – delta-9-tetrahydrocannabinol gave rise to the word “cannabinoids.” The THC in marijuana alters the brain’s activity; and experience of this altered brain functioning is what people call being “high.” But scientists were still curious and they wanted to know more about how THC is able to interact with the brain and what parts of the brain are altered. First, researchers labeled cannabinoid molecules with a marker that enabled them to visualize where THC goes in the brain. They found that, at first, THC spreads evenly throughout […]
[…]talk to your family doctor. Visit familydoctor.org for information on this and many other health-related topics. Copyright © 2002 by the American Academy of Family Physicians.Permission is granted to print and photocopy this material for nonprofit educational uses. Written permission is required for all other uses, including electronic […]
[…]
[…]mandatory minimum sentences for fentanyl analogues. And it would permanently make all fentanyl-related substances Schedule I without first testing them for benefits or harm. Criminalization has failed to keep us safer. Instead, itâs actually fueling the tragic overdose crisis. Increasing penalties will only make things worse. Saving lives requires a health approach, not more punishment. This bill is a step in the wrong direction. Help us to oppose it: tell your Representative to vote against the HALT Fentanyl Act right now. We expect this vote to be close so itâs vital for constituents like you to also make… Read […]
[…]Tobacco Cessation in Substance Use Treatment: Research & Policy Efforts to Reduce Tobacco-Related Health Inequality by Chwen-Yuen Angie Chen MD FACP FASAM, and A 50 Year CSAM Celebration! Read the Newsletter […]
[…]opioid epidemic is not going away, and in fact is worsening as it evolves to include stimulant-related deaths, fentanyl and its analogues and now xylazine, maintaining its grip on our patients, friends, families, and communities. So letâs âpay it forwardâ â and donate to MERF today! While $1500 will fund one Scholar this year, we welcome all donations â even larger ones! If your organization has a charitable foundation, let us know whom to contact with our âask.â Better yet, help us get a foot in that door! Dr. Garrett OâConnor brought his indomitable force in refocusing MERF in 2000 […]
[…]its plans. 4. TREATMENT, NOT PRISON Our courts and prisons are overburdened by nonviolent drug-related oâąâąenders. CSAM believes that the social disruptions caused by disease are best ameliorated by medical treatment. Evidence proves that treatment is more effective in reducing recidivism and more economical than incarceration. CSAM advocates annual (cost of living) budget increases for Proposition 36 (Substance Abuse and Crime Prevention Act, Public Initiative 2000). CSAM opposes proposed 2007 state funding cuts to Prop 36 disguised as county matching plans. CSAM supports stratiïŹcation of courts and treatment providers, with clinical case management for high utilizers and drug courts for more […]
[…]Medicine Review Course Conference. We encourage physicians, residents, medical students, and non-physician healthcare professionals from diverse organizations and fields to apply. SUBMISSION INFORMATION Proposals may include projects that are in progress or those that will be done by the time of the conference, be relevant to addiction medicine education or practice, using evidence-based information. Proposals are invited from healthcare professionals as well as trainees involved in different aspects of providing addiction treatment. We are committed to providing a platform for new and emerging talent (trainees, early career professional) as well as seasoned practitioners. Submissions received on or before 6/1/24 will […]
[…]COVID-19 Page Also check out ASAM’s COVID-19 Resource Page . (Updated 9/18/2020) Information for Children Trinka and Sam Fighting the Big Virus: Trinka, Sam, and Littletown Work Together.This is a story and workbook to help young children talk about their feelings related to COVID-19. This resource is available in English and Spanish . Recent Informative Articles Low-cost Measurement of Face Mask Efficacy for Filtering Expelled Droplets During Speech (Sep 2, […]
[…]into our communities â while prioritizing harm reduction strategies to reduce overdoses and compassionately help those struggling with substance use and addiction.âView the Master […]
[…]decisions. RESOURCES CSAM Policy Statement on Cannabis (October 2015) Mitigation of Marijuana-Related Legal Harms to Youth in CaliforniaPeter Banys, M.D., M.Sc. (2016), Journal of Psychoactive Drugs Marijuana Legalization in California: Rational Implementation of the Adult Use of Marijuana Act (AUMA)Peter Banys M.D., M.Sc. & Timmen L. Cermak M.D. (2015), Journal of Psychoactive Drugs Clinical Approach to the Heavy Cannabis User in the Age of Medical MarijuanaTimmen L. Cermak M.D. (2016), Journal of Psychoactive Drugs Prevention of Youthful Marijuana UseTimmen L. Cermak M.D. & Peter Banys M.D., M.Sc. (2016), Journal of Psychoactive Drugs Recommendations to Improve the Adult Use of Marijuana […]
[…]The California Society of Addiction Medicine (CSAM) has worked hard to advance the ethical and compassionate treatment of addiction through physician-led education of health professionals, patients, and the public. The Society promotes practice, research, prevention, and implementation of evidence-based treatment and sound drug policy. We advocate for our patients, their families, and other support systems at all stages of care. CSAM is a 501(c)(3) organization. Your donation is 100% tax-deductible. Tax ID: 23-7364605 If you have specific questions about how your gift is being used, or you want further information on how to continue your support, please donât hesitate to […]
[…]however, this pathway will expire in 2025. Upon expiration of the practice-based pathway, a one-year fellowship will be required to become an addiction medicine specialist for those who hold a primary ABMS board certification. The Addiction Medicine Certification Hub Addiction Medicine Official ABMS Subspecialty Transition to Board Certification Under ABPM FAQs Licensure How to Meet the Continuing Medical Education (CME) Requirement for Physicians & Surgeons Learn more about the specialty of addiction medicine, information about fellowships, board exam information resources, and more. Continuing Medical Education Standards Cultural & Linguistic Competency and Implicit Bias AB 241 | AB […]
[…]submit a nomination on their behalf. Please submit your nomination by June 15, 2023! Recognizing non-physicians who make outstanding contributions to the community The Community Service award recognizes a non-physician who made outstanding contributions to the community. This CSAM award is presented based on merit and since 1985, it has been awarded to a wide variety of legislators, activists, community leaders, etc., all with one thing in common: they have improved the lives of those suffering from the disease of addiction, and by doing so have contributed a valuable service to the community. This award will be presented to the selected candidate […]
Registration Now Open for the CSAM 2024 Conference! New Courses Available at the CSAM Education Center! New Courses from the 2023 CSAM Conference Include: 50th Anniversary History Book Purchase your copy of the 50th Anniversary History Book Today for $60. Supplies are Limited! The History Book is also viewable online […]
CSAM News Spring […]
Winter 2019 CSAM […]
